The Use of Intravenous Fosfomycin in Clinical Practice: A 5-Year Retrospective Study in a Tertiary Hospital in Italy

Fosfomycin in intravenous (IV) formulation has re-emerged as a valuable tool in the treatment of multi-drug resistant (MDR) and extensively drug-resistant (XDR) infections because of its broad spectrum of antibacterial action and pharmacokinetic characteristics. This retrospective study aimed to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Anastasia, Antonio, Bonura, Silvia, Rubino, Raffaella, Giammanco, Giovanni Maurizio, Miccichè, Irene, Di Pace, Maria Rita, Colomba, Claudia, Cascio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295113/
https://www.ncbi.nlm.nih.gov/pubmed/37370290
http://dx.doi.org/10.3390/antibiotics12060971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295113/
https://www.ncbi.nlm.nih.gov/pubmed/37370290
http://dx.doi.org/10.3390/antibiotics12060971

Ejemplares similares